Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

General Motors (GM) Declines More Than Market: Some Information for Investors
General Motors (GM) Declines More Than Market: Some Information for Investors

General Motors (GM) ended the recent trading session at $81.32, demonstrating a -1.23% change from the preceding day's closing price. This change lagged the S&P 500's 0.74% loss on the day

Here's Why Datadog (DDOG) Fell More Than Broader Market
Here's Why Datadog (DDOG) Fell More Than Broader Market

Datadog (DDOG) closed at $135.99 in the latest trading session, marking a -1.08% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.74%. Elsewhere, the Dow saw

Constellation Energy Corporation (CEG) Declines More Than Market: Some Information for Investors
Constellation Energy Corporation (CEG) Declines More Than Market: Some Information for Investors

Constellation Energy Corporation (CEG) closed the most recent trading day at $353.27, moving -1.08% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of

Here's Why First Solar (FSLR) Fell More Than Broader Market
Here's Why First Solar (FSLR) Fell More Than Broader Market

First Solar (FSLR) closed the most recent trading day at $261.23, moving -1.16% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.74%. On the other

GE Aerospace (GE) Declines More Than Market: Some Information for Investors
GE Aerospace (GE) Declines More Than Market: Some Information for Investors

GE Aerospace (GE) closed the most recent trading day at $308.03, moving -1.21% from the previous trading session. This change lagged the S&P 500's daily loss of 0.74%. Meanwhile, the Dow experienced

AppLovin (APP) Registers a Bigger Fall Than the Market: Important Facts to Note
AppLovin (APP) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest close session, AppLovin (APP) was down 2.87% at $673.82. The stock trailed the S&P 500, which registered a daily loss of 0.74%. Elsewhere, the Dow lost 0.63%, while the tech-heavy

Toll Brothers (TOL) Falls More Steeply Than Broader Market: What Investors Need to Know
Toll Brothers (TOL) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest close session, Toll Brothers (TOL) was down 1.01% at $135.22. This move lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow lost 0.63%, while the tech-heavy Nasdaq lost 0.76%

ACM Research, Inc. (ACMR) Suffers a Larger Drop Than the General Market: Key Insights
ACM Research, Inc. (ACMR) Suffers a Larger Drop Than the General Market: Key Insights

ACM Research, Inc. (ACMR) closed at $39.45 in the latest trading session, marking a -1.87% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.74% for the day

AMC Entertainment (AMC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
AMC Entertainment (AMC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

AMC Entertainment (AMC) closed at $1.56 in the latest trading session, marking a -3.11% move from the prior day. This change lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow saw a

Super Micro Computer (SMCI) Suffers a Larger Drop Than the General Market: Key Insights
Super Micro Computer (SMCI) Suffers a Larger Drop Than the General Market: Key Insights

Super Micro Computer (SMCI) closed at $29.27 in the latest trading session, marking a -1.28% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.74% for the

FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026: https://www.marketbeat.com/logos/articles/med_20251231095435_fda-approves-novo-nordisks-wegovy-pill-a-game-chan.png
FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026

After a year that has been anything but smooth sailing, pharmaceutical giant Novo Nordisk A/S (NYSE: NVO) is closing out 2025 on a positive note. Shares received a significant 7% boost on Dec. 23

Sleeping With the Enemy: Inside the NVIDIA-Intel Deal: https://www.marketbeat.com/logos/articles/med_20251231093220_sleeping-with-the-enemy-inside-the-nvidia-intel-de.png
Sleeping With the Enemy: Inside the NVIDIA-Intel Deal

For over a decade, the semiconductor industry was defined by a rivalry between Intel (NASDAQ: INTC) and NVIDIA (NASDAQ: NVDA). One company dominated the Central Processing Unit (CPU) market that

Rivian's 57% Surge: Head Fake, or Sign of a 2026 Sea-Change?: https://www.marketbeat.com/logos/articles/med_20251231084634_rivians-57-surge-head-fake-or-sign-of-a-2026-sea-c.png
Rivian's 57% Surge: Head Fake, or Sign of a 2026 Sea-Change?

Despite disappointing performance throughout most of 2025, shares of Rivian Automotive (NASDAQ: RIVN) are finishing the year strong. Through the Nov. 4 close, the automaker was down 6% in 2025

3 Best Earnings Acceleration Stocks to Buy for 2026
3 Best Earnings Acceleration Stocks to Buy for 2026

In 2026, savvy investors will likely focus on companies that deliver consistent earnings growth, signaling profitability. However, earnings acceleration has an even greater effect on driving stock

Quantum Investing in 2026: Hit the Jackpot With the Best 3 Stocks
Quantum Investing in 2026: Hit the Jackpot With the Best 3 Stocks

For equity investors looking beyond incremental AI investments, quantum computing is emerging as one of the most lucrative opportunities heading into 2026. Industry estimates show the global quantum

Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months

Shares of Replimune Group REPL have surged 131.1% over the past three months, fueled by positive regulatory updates.

In October, the FDA accepted the resubmission of the biologics license

Will the Fed Cut or Pause? These Finance Stocks Can Win Either Way: https://www.marketbeat.com/logos/articles/med_20251230160722_will-the-fed-cut-or-pause-these-finance-stocks-can.png
Will the Fed Cut or Pause? These Finance Stocks Can Win Either Way

Will they or won’t they? Stocks have moved higher in the last quarter of 2025 as the Federal Reserve started to cut interest rates. However, investors are wondering what’s next. There are

3 Beaten-Down Stocks That Could Rebound in 2026
3 Beaten-Down Stocks That Could Rebound in 2026

As I look ahead to 2026 and search for compelling investment opportunities, one productive place to focus is on stocks that lagged during an otherwise strong year for U.S. equities. The broader

Advanced Micro Devices Is the Most Compelling AI Trade for 2026: https://www.marketbeat.com/logos/articles/med_20251230144621_advanced-micro-devices-is-the-most-compelling-ai-t.png
Advanced Micro Devices Is the Most Compelling AI Trade for 2026

Advanced Micro Devices (NASDAQ: AMD) appears to be one of the most compelling AI setups for 2026, due to the company's position in the GPU market and the expected launch of its MI450 line, which

Why You Should Add Encompass Health to Your Portfolio Now
Why You Should Add Encompass Health to Your Portfolio Now

Encompass Health Corporation EHC is aided by growing patient volumes, frequent expansion initiatives and a strong financial position.

EHC’s Zacks Rank & Upbeat Price Performance

Encompass Health

Daktronics (DAKT) is an Incredible Growth Stock: 3 Reasons Why
Daktronics (DAKT) is an Incredible Growth Stock: 3 Reasons Why

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Core & Main (CNM) is an Incredible Growth Stock: 3 Reasons Why
Core & Main (CNM) is an Incredible Growth Stock: 3 Reasons Why

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Microsoft Is Lagging the Market—But Its Moat May Matter More in 2026: https://www.marketbeat.com/logos/articles/med_20251230152736_microsoft-is-lagging-the-marketbut-its-moat-may-ma.png
Microsoft Is Lagging the Market—But Its Moat May Matter More in 2026

It’s not often that investors have heard the words Microsoft (NASDAQ: MSFT) and “market laggard” in the same sentence. But that’s the situation with MSFT stock with just a few trading sessions

Will OSI (OSIS) Beat Estimates Again in Its Next Earnings Report?
Will OSI (OSIS) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering OSI Systems (OSIS), which belongs to the Zacks

Can K12 (LRN) Keep the Earnings Surprise Streak Alive?
Can K12 (LRN) Keep the Earnings Surprise Streak Alive?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering K12 (LRN), which belongs to the Zacks Schools